Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Cinnamedrine

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Cinnamedrine
Clinical data
Other namesCinnamylephedrine;N-Cinnamylephedrine
Identifiers
  • 2-[methyl-[(E)-3-phenylprop-2-enyl]amino]-1-phenylpropan-1-ol
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.001.838Edit this at Wikidata
Chemical and physical data
FormulaC19H23NO
Molar mass281.399 g·mol−1
3D model (JSmol)
  • CC(C(C1=CC=CC=C1)O)N(C)C/C=C/C2=CC=CC=C2
  • InChI=1S/C19H23NO/c1-16(19(21)18-13-7-4-8-14-18)20(2)15-9-12-17-10-5-3-6-11-17/h3-14,16,19,21H,15H2,1-2H3/b12-9+
  • Key:YMJMZFPZRVMNCH-FMIVXFBMSA-N

Cinnamedrine (INNTooltip International Nonproprietary Name,USANTooltip United States Adopted Name), also known asN-cinnamylephedrine, is asympathomimeticdrug with similar effects relative to those ofephedrine.[1][2] It also has somelocal anesthetic activity.[2] Cinnamedrine was previously used, in combination withanalgesics, as anantispasmodic to treatdysmenorrhea in theover-the-counterdrugMidol in the 1980s.[2][3] There is acase series of the drug beingabused as apsychostimulant.[4]

See also

[edit]

References

[edit]
  1. ^J. Elks (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 279–.ISBN 978-1-4757-2085-3.
  2. ^abcI.K. Morton; Judith M. Hall (6 December 2012).Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 77–.ISBN 978-94-011-4439-1.
  3. ^William Andrew Publishing (22 October 2013).Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 1027–.ISBN 978-0-8155-1856-3.
  4. ^Fellows KW, Giannini AJ (1983). "Cinnamedrine: potential for abuse".J. Toxicol. Clin. Toxicol.20 (1):93–9.doi:10.3109/15563658308990054.PMID 6887304.
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Phenethylpyrrolidines
Racetams
Psychedelics
Tropanes
Tryptamines
Others
DRAsTooltip Dopamine releasing agents
NRAsTooltip Norepinephrine releasing agents
SRAsTooltip Serotonin releasing agents
Others
Calcium
VDCCsTooltip Voltage-dependent calcium channels
Blockers
Activators
Potassium
VGKCsTooltip Voltage-gated potassium channels
Blockers
Activators
IRKsTooltip Inwardly rectifying potassium channel
Blockers
Activators
KCaTooltip Calcium-activated potassium channel
Blockers
Activators
K2PsTooltip Tandem pore domain potassium channel
Blockers
Activators
Sodium
VGSCsTooltip Voltage-gated sodium channels
Blockers
Activators
ENaCTooltip Epithelial sodium channel
Blockers
Activators
ASICsTooltip Acid-sensing ion channel
Blockers
Chloride
CaCCsTooltip Calcium-activated chloride channel
Blockers
Activators
CFTRTooltip Cystic fibrosis transmembrane conductance regulator
Blockers
Activators
Unsorted
Blockers
Others
TRPsTooltip Transient receptor potential channels
LGICsTooltip Ligand gated ion channels
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds


Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Cinnamedrine&oldid=1251745036"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp